Article
Identification and Verification of Molecular Subtypes with Enhanced Immune Infiltration Based on m6A Regulators in Cutaneous Melanoma.
BioMed research international - 1 Jan 2021
Lin Yitong, Wang Shu, Liu Shirui, Lv Sha, Wang Huayang, Li Fuqiu
Abstract excerpt
BACKGROUND: As the most aggressive type of skin cancer, cutaneous melanoma (CM) is experiencing a rapidly rising mortality in recent years. Exploring potential prognostic biomarkers or mechanisms of disease progression therefore has a great significance for CM. The purpose of this study was to identify genetic markers and prognostic performance of N6-methyladenosine (m6A) regulators in CM. METHOD: Gene expression...
Topics
Join the communities discussing this publication.
